Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03824652

WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Stephen Freedland · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized control trial testing the effect of walnut supplementation on prostate cancer progression in 50 men with biopsy confirmed prostate cancer and planning to undergo RP. Patients consented to the study will be randomly assigned to either continue their usual diets (control arm) or to the walnut arm for 4-10 weeks depending on the window between their consent date and the date for RP.

Detailed description

The overall objective of this study is to test the effect of walnuts added to a usual diet on prostate cancer progression as measured by Ki67 expression in the prostate tissues. Subjects will be randomized 1:1 to usual diet or usual diet with the addition of 2 ounces of walnuts daily. The baseline visit will occur in conjunction with a standard of care visit post-biopsy, the intervention period will range from 4-10 weeks dependent upon the scheduled date of the standard of care radical prostatectomy (RP), and the final visit will occur in conjunction with a standard of care visit prior to RP.

Conditions

Interventions

TypeNameDescription
OTHERwalnuts2 ounces of walnuts daily for 4-10 weeks
OTHERusual dietSubject continues usual diet
OTHERphone counseling with dietitianWeekly calls with dietitian

Timeline

Start date
2019-04-22
Primary completion
2026-06-01
Completion
2027-06-01
First posted
2019-01-31
Last updated
2026-02-04

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03824652. Inclusion in this directory is not an endorsement.